US 12336973
Cancer therapeutic compositions and methods targeting DNAse1L3
granted A61KA61K31/198A61K31/255
Quick answer
US patent 12336973 (Cancer therapeutic compositions and methods targeting DNAse1L3) held by Providence Health & Services—Oregon expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Providence Health & Services—Oregon
- Grant date
- Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/198, A61K31/255, A61K31/53, A61K31/7105